✨
AI Summary & Key Takeaways
AI Insight⚡ TL;DR(Too Long; Didn't Read)
In our case, we discussed that aripiprazole-related sialorrhea developed in a male patient who treated with amitriptyline.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Treatment compatibility is crucial for the psychiatric disorders.
📊
Key Findings & Data:This can be provided with the low side effect profile of psychotropic drugs.
💡
Conclusion & Impact:In our case, we discussed that aripiprazole-related sialorrhea developed in a male patient who treated with amitriptyline.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Treatment compatibility is crucial for the psychiatric disorders. This can be provided with the low side effect profile of psychotropic drugs. Aripiprazole, a tolerable and safe antipsychotic, is used in the treatment of various psychiatric disorders. In the previous studies, sialorrhea was declared as a side effect of some antipsychotics. Furthermore, aripiprazole-related sialorrhea which was treated with diphenhydramine and trihexyphenidly, was reported in the literature. In our case, we discussed that aripiprazole-related sialorrhea developed in a male patient who treated with amitriptyline.
🔖
Cite This Article
EBRİNC, S., ISPİR, M., GUNDOGMUS, I., KİYANCİCEK, M., KULLAKCİ, H., MADEN, O., ALGUL, A. (2022). Aripiprazole-induced sialorrhea responsive to amitriptyline treatment. Journal of Mood Disorders, Cilt: 7 - Sayı: 3, 176–178. https://ajindex.com/articles/564510